![](https://www.diabetesnews.com/wp-content/uploads/2013/06/20100824_-medtronic-headquarters_33-150x150.jpg)
Medtronic Diabetes shared new timeline hopes on its upcoming diabetes device pipeline at the JP Morgan Healthcare Conference on January 12. Notably, management expects to launch the MiniMed 640G/Enlite 3 CGM (predictive low glucose management) in the US by April 2016, and a hybrid closed loop system (one step closer to a fully automated ‘artificial pancreas’) – the MiniMed 670G – by April 2017!